Guarda et al., 2011 [268] demonstrated that IL-1β generation by primary monocytes was less in multiple sclerosis patients administered IFN-β in comparison to healthy individuals, bolstering the worth of IFN-β intervention. The gene discussed is IFNB1; the disease is multiple sclerosis.